Posts filtered by tags: Merck Sharp Dohme Corp[x]


 

Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin. The biosimilar, Ontruzant, is sold by Merck Sharp & Dohme Corp, a unit of Merck & Co Inc, and is developed by Samsung Bioepis Co Ltd, which is a joint venture between Samsung BioLogics and Biogen Inc. The approval https://twitter.com/FDA_Drug_Info/status/1086327386059157504 comes just a few weeks after the health regulator gave Celltrion Inc's ...
Tags: Science, Samsung, Fda, U S Food and Drug Administration, Roche, Merck Co Inc, Biogen Inc, Samsung BioLogics, Roche Holding AG, Celltrion Inc, Samsung Bioepis Co Ltd, Merck Sharp Dohme Corp, Herzuma


Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nod

The U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, Herceptin. The biosimilar, Ontruzant, is co-developed by Merck Sharp & Dohme Corp, a unit of Merck & Co Inc, and Samsung Bioepis Co Ltd, which is a joint venture between Samsung BioLogics and Biogen Inc. The approval https://twitter.com/FDA_Drug_Info/status/1086327386059157504 comes just a few weeks after the health regulator gave Celltrion Inc's Herzuma ...
Tags: Science, Samsung, Fda, U S Food and Drug Administration, Roche, Merck Co Inc, Biogen Inc, Samsung BioLogics, Roche Holding AG, Celltrion Inc, Samsung Bioepis Co Ltd, Merck Sharp Dohme Corp, Herzuma


United States: Albrecht Oral Argument – Better Us Than Them - Reed Smith

We've reviewed the transcript of the oral argument in Merck Sharp & Dohme Corp. v. Albrecht, No. 17-290 (U.S.), e.g., the United States Supreme Court appeal from the horrible decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation.
Tags: News, United States, Reed Smith, Albrecht, Merck Sharp Dohme Corp, U S e g the United States Supreme Court


Now available on Oyez: This week’s oral argument audio aligned with the transcripts

Oyez has posted the aligned audio and transcripts from this week’s oral arguments at the Supreme Court. The court heard argument this week in: Merck Sharp & Dohme Corp. v. Albrecht Obduskey v. McCarthy & Holthus LLP Herrera v. Wyoming Fourth Estate Public Benefit Corp. v. Wall-Street.com Franchise Tax Board of California v. Hyatt   The post Now available on Oyez: This week’s oral argument audio aligned with the transcripts appeared first on SCOTUSblog.
Tags: Supreme Court, Law, Hyatt, Oyez, Merits Cases, Merck Sharp Dohme Corp, Wyoming Fourth Estate Public Benefit Corp, Albrecht Obduskey, McCarthy Holthus LLP Herrera, Wall Street com Franchise Tax Board of California


Argument analysis: Gleaning the FDA’s meaning for impossibility pre-emption

Much of the federal government may be in shutdown mode, but the Supreme Court is still open for business. The Supreme Court opened its January session Monday morning with argument in Merck Sharp & Dohme Corp. v. Albrecht, a case about the workings of the Food & Drug Administration (still partially open) and when the agency’s actions may insulate drug manufacturers from state tort suits through “impossibility pre-emption.” An important and often-used litigation defense for manufacturers, impossib...
Tags: Featured, Supreme Court, Law, Merck, United States, Fda, Sonia Sotomayor, Stewart, John Roberts, Albrecht, Roberts, Ginsburg, Levine, Sotomayor, Stephen Breyer, Breyer


Argument transcripts

The transcript of oral argument in Merck Sharp & Dohme Corp. v. Albrecht is available on the Supreme Court’s website; the transcript in Obduskey v. McCarthy & Holthus LLP is also available.   The post Argument transcripts appeared first on SCOTUSblog.
Tags: Supreme Court, Law, Albrecht, Merits Cases, Merck Sharp Dohme Corp, Obduskey, McCarthy Holthus LLP


This week at the court

The Supreme Court will release additional orders from the January 4 conference on Monday at 9:30 a.m. There is a possibility of opinions on Tuesday at 10 a.m. On Monday, the justices hear oral argument in Merck Sharp & Dohme Corp. v. Albrecht and Obduskey v. McCarthy & Holthus LLP. On Tuesday, the justices hear oral argument in Herrera v. Wyoming and Fourth Estate Public Benefit Corp. v. Wall-Street.com. On Wednesday, the justices hear oral argument in Franchise Tax Board of California v. Hyatt....
Tags: Supreme Court, Law, Wyoming, Hyatt, Albrecht, Herrera, This Week at the Court, Franchise Tax Board of California, Merck Sharp Dohme Corp, Fourth Estate Public Benefit Corp, Obduskey, McCarthy Holthus LLP


Justices release January calendar

The Supreme Court will ring in 2019 with a nearly full argument calendar. Today the justices released the calendar for the January 2019 sitting, which begins on January 7. The justices will hear oral argument in five cases (two per day on Monday and Tuesday, followed by one on Wednesday) during the first week of the sitting; during the second week, they will hear oral argument in six cases, two per day from Monday through Wednesday. One of the last cases of the sitting will be familiar to eight ...
Tags: Supreme Court, Law, United States, Food And Drug Administration, Medicare, Jackson, Blair, Howe, Department of Health and Human Services, Tennessee Valley Authority, Kavanaugh, Herrera, Thacker, Goldstein Russell, Rimini Street Inc, Merits Cases


VC-backed Sutro Biopharma debuts IPO

South San Francisco-based Sutro Biopharma Inc, a drug developer focused on creating protein therapeutics for cancer and autoimmune disorders, has raised about $85 million after pricing its over 5.6 million shares at $15 per share. The stock began trading September 27, 2018 on the NASDAQ under the ticker symbol “SRO.” Cowen and Piper Jaffray are the lead underwriters. Also, Sutro has raised about $10 million in a private placement from Merck. Sutro’s pre-IPO investors included Samsara BioCapital,...
Tags: Minneapolis, Trends, IPOs, Healthcare, Nasdaq, Securities And Exchange Commission, Piper Jaffray, Wedbush, JMP Securities, South San Francisco, Cowen, Sutro, Nasdaq Global Market, South San Francisco California, Sutro Biopharma Inc, Long Island Avenue Edgewood NY


Empirical SCOTUS: The big business court

The current Supreme Court is friendly toward big business. How friendly? If the court’s trajectory continues, perhaps as friendly as any court dating back to the Lochner era, when laissez-faire policies permeated the court’s rulings. Prominent scholars, most notably Lee Epstein, William Landes and Richard Posner, have found empirical support for the proposition that the current court is more pro-business than previous iterations. (That study was recently updated through the 2015 term.) This post...
Tags: Apple, Featured, Supreme Court, Law, Wall Street, Los Angeles, ExxonMobil, Pepper, South Dakota, Citizens United, Archer, Warren, Exxon, Kennedy, Paul Clement, Securities And Exchange Commission


United States: Breaking News – Supreme Court Grants Review In Fosamax Preemption Case - Reed Smith

Today, on the last day of the United States Supreme Court's 2018 Term, the Court issued an order granting review in Merck Sharp & Dohme Corp. v. Albrecht, No. 17-290 – which is the Supreme Court docket name
Tags: News, Supreme Court, Court, United States, Breaking News, Albrecht, United States Supreme Court, Merck Sharp Dohme Corp


Live blog of orders (Update: Completed)

We live-blogged to discuss Justice Anthony Kennedy’s retirement and the Supreme Court’s orders from its final conference of the term. Former Kennedy clerks Jeffrey Pojanowski and Michael Dorf joined us. The justices added seven new cases to their merits docket for next term: Herrera v. Wyoming, Fourth Estate Public Benefit Corp. v. Wall-Street.com, Gamble v. United States, Nieves v. Bartlett, Franchise Tax Board of California v. Hyatt, Obduskey v. McCarthy & Holthus LLP and Merck Sharp & Dohme C...
Tags: Supreme Court, Law, Live, Kennedy, Albrecht, Michael Dorf, Anthony Kennedy, Herrera, Merck Sharp Dohme Corp, United States Nieves, McCarthy Holthus LLP, Jeffrey Pojanowski, Wyoming Fourth Estate Public Benefit Corp, Wall Street com Gamble, Bartlett Franchise Tax Board of California, Hyatt Obduskey


Relist Watch: The final countdown

John Elwood provides his best guess about October Term 2017’s last relists. Every June, before the justices leave town, they have one last impromptu conference to consider – and usually dispose of – all the cases relisted after their last scheduled conference. In recent years, that has overwhelmingly happened on the last Monday of June, which is also typically when the court hands down the last opinions of the term; the resulting order list is usually released the following day. They’re running ...
Tags: Hope, Featured, Mississippi, Supreme Court, Greece, Law, Congress, Merck, Indiana, United States, Wyoming, Missouri, Idaho, Food And Drug Administration, Miami, Evans


Cheapest Drugs Online. amaryl versus januvia. Best Place To Order Generics

amaryl versus januvia Generic Januvia Best Pharmacy To Buy Cheapest Januvia. Januvia is a daily oral tablet used to treat type 2 diabetes. When combined with healthy diet and exercise, Generic Januvia works to control blood sugar levels and regulate insulin levels naturally produced by the body. Treat your diabetes the easy way, and reduce the risk of kidney damage, nerve disorders, impotency, heart attack, stroke and other conditions that may arise from high blood sugar levels, wi...
Tags: Uncategorized, Merck Sharp Dohme Corp, Januvia, Januvia Januvia, Januvia Sitagliptin Januvia


United States: Federal Circuit Splits On Approach To Analyzing Graham Factors - BakerHostetler

In Merck Sharp & Dohme Corp. v. Hospira, Inc.,[1] the Federal Circuit affirmed the lower court's ruling that the asserted claims of Merck's U.S. Patent No. 6,486,150 (the '150 patent) were obvious
Tags: News, Merck, United States, Federal Circuit, Hospira Inc, Merck Sharp Dohme Corp


United States: Process Discoverable By "Merely Ordinary Experimentation" Rendered Obvious - Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

In Merck Sharp & Dohme Corp. v. Hospira, Inc., No. 2017-1115 (Fed. Cir. Oct. 26, 2017), a divided Federal Circuit panel affirmed the district court's finding that a claimed process for making a chemical compound was obvious.
Tags: News, United States, Federal Circuit, Hospira Inc, Fed Cir, Finnegan Henderson Farabow Garrett, Dunner LLP, Merck Sharp Dohme Corp


Merck Sharp & Dohme Corp. v. Hospira, Inc. (Fed. Cir. 2017)

By Kevin E. Noonan -- The Federal Circuit continues its explication of the law of obviousness post-KSR Int'l. v. Teleflex Inc. (and Judge Pauline Newman continues to disagree with her brethren in some regards) in a decision handed down last Friday, in Merck Sharp & Dohme Corp. v. Hospira, Inc. The case arose in an ANDA litigation between innovator Merck and generic drug manufacturer Hospira over the antibiotic ertapenem, sold by Merck under the brand name Invanz®. The drug, known to be chemicall...
Tags: Law, Merck, Pauline Newman, Federal Circuit, Hospira Inc, Hospira, Patent Docs, Obviousness, Kevin E Noonan, Merck Sharp Dohme Corp, Teleflex Inc, Hospira Inc Fed, KSR Int l, Merck Sharp amp ; Dohme Corp


Safe Buy 50 mg Januvia cheapest * Worldwide Shipping (1-3 Days) * No Script Online Pharmacy

Safe Buy 50 mg Januvia cheapest Generic Januvia Best Pharmacy To Order Cheap Januvia without prescription. Januvia is a daily oral tablet used to treat type 2 diabetes. When combined with healthy diet and exercise, Generic Januvia works to control blood sugar levels and regulate insulin levels naturally produced by the body. Treat your diabetes the easy way, and reduce the risk of kidney damage, nerve disorders, impotency, heart attack, stroke and other conditions that may arise fr...
Tags: General, Trends, Worldwide Shipping, Merck Sharp Dohme Corp, Januvia, Januvia Sitagliptin Januvia, Januvia Belgium


Safe Pharmacy To Buy Generics – Januvia Cheap Buy – Free Worldwide Shipping

Januvia Cheap Buy Generic Januvia How To order Januvia. Januvia is a daily oral tablet used to treat type 2 diabetes. When combined with healthy diet and exercise, Generic Januvia works to control blood sugar levels and regulate insulin levels naturally produced by the body. Treat your diabetes the easy way, and reduce the risk of kidney damage, nerve disorders, impotency, heart attack, stroke and other conditions that may arise from high blood sugar levels, with Generic Januvia. ...
Tags: General, Trends, Merck Sharp Dohme Corp, Januvia, Januvia Januvia, Januvia Sitagliptin Januvia, Januvia MiamiBuy Cheap Januvia, Ligne Order Cheap Januvia, Januvia San FranciscoCosto Del Januvia, SitagliptinKöp Online Januvia Houston


Generic Januvia Order Discount Pharmacy Online Pills Online Without Prescription

Generic Januvia Order Generic Januvia Safe Place To Buy Generic Januvia OTC. Januvia is a daily oral tablet used to treat type 2 diabetes. When combined with healthy diet and exercise, Generic Januvia works to control blood sugar levels and regulate insulin levels naturally produced by the body. Treat your diabetes the easy way, and reduce the risk of kidney damage, nerve disorders, impotency, heart attack, stroke and other conditions that may arise from high blood sugar levels, wi...
Tags: General, Trends, Merck Sharp Dohme Corp, Januvia, Januvia Sitagliptin Januvia, Januvia Denmark, Billig Cheap Januvia, Januvia San Francisco Purchase Cheap Januvia, Januvia Seattle Purchase Cheap Januvia France


Israel: The Israeli Supreme Court: Patent Rights Do Not Override Patients' Rights! - S Horowitz & Co

The Supreme Court allowed an appeal filed by The Manufacturers Association of Israel, but denied that filed by Merck Sharp & Dohme Corp., thereby determining that MSD's patent term extension for ezetimibe has expired.
Tags: News, Supreme Court, Israel, HOROWITZ, Israeli Supreme Court, Merck Sharp Dohme Corp, Manufacturers Association of Israel


PTAB Life Sciences Report -- Part I

By John Cravero -- About the PTAB Life Sciences Report: Each month we will report on developments at the PTAB involving life sciences patents. Merck Sharp & Dohme Corp. v. Genentech, Inc. PTAB Petition: IPR2017-00047; filed October 11, 2016. PTAB Trial Instituted Document entered January 3, 2017. Patent at Issue: U.S. Patent No. 6,331,415 ("Methods of producing immunoglobulins, vectors and transformed host cells for use therein," issued December 18, 2001) claims a process for producing an immuno...
Tags: Law, Patent Trial and Appeal Board, Genentech Inc, Patent Docs, Post-Grant Proceedings, John Cravero, Merck Sharp Dohme Corp